Rosen Law Firm is investigating potential securities claims for shareholders of Blaize Holdings following allegations that the company issued misleading business information. The investigation follows a report by short seller Pelican Way Research accusing Blaize's $50 million deal with NeoTensr of being fraudulent, which caused Blaize's stock to drop 12% on April 28, 2026. Investors who purchased Blaize securities may be eligible for compensation through a class action lawsuit being prepared by Rosen Law Firm, which specializes in securities litigation and has a strong track record of recovering losses for investors.
Dogecoin (DOGE) surged 10% to around $0.078, driven by a broader memecoin market rally and integration with Paxos, which powers PayPal and Venmo payments. This move coincided with increased trading volume and open interest in DOGE futures, supported ...
The OM token fell 18.5% to a record low of $0.004126 following an emergency shutdown of the MANTRA blockchain due to an unidentified security incident. All network activity, including block production and transactions, was suspended as the team inves...
South Korea's Upbit exchange added four new altcoins—ETHGas (GWEI), Biconomy (BICO), Bubblemaps (BMT), and Nillion (NIL)—with trading pairs in BTC and USDT. ETHGas saw the biggest immediate price jump of about 11%, while the others rose over 7%. Trad...
Tekcapital's portfolio company Guident has signed a 36-month agreement with Coastal Waste & Recycling to deploy its WatchBot autonomous inspection robots and AI software across more than 40 Coastal locations. The system will conduct facility patrols,...
Corcept Therapeutics is rated Strong Buy with price targets of $163 in one year and $222 in two years, driven by rapid revenue and margin growth. The company’s new drug Lifyorli is launching quickly for platinum-resistant ovarian cancer, and Korlym c...
